- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT06251661
Riabilitazione Cognitiva Multisensoriale sulla Funzione degli Arti Superiori e sull'Affaticamento nell'Ictus
Riabilitazione cognitiva multisensoriale sulle funzioni degli arti superiori e sull'affaticamento in diversi gradi di spasticità nei pazienti con ictus
This interventional study aims to investigate the therapeutic efficacy of Cognitive multi-sensory rehabilitation (CMR) on upper limb function and fatigue in chronic stroke patients. The main question is:
• Does cognitive multi-sensory rehabilitation significantly affect upper limb function and fatigue in stroke patients? Participants will be assigned into two groups. They will receive 12 sessions of study group CMR and traditional physical therapy and control group traditional physical Therapy rehabilitation. CMR 40 minutes immediately followed by 20 minutes of selected physical therapy program, three sessions per week for four weeks.
Panoramica dello studio
Stato
Intervento / Trattamento
Descrizione dettagliata
About 70% of people with stroke are unable to use their affected hand efficiently in activities of daily living. Further, post-stroke fatigue affects up to 92% of post-stroke patients. Post-stroke fatigue is a multifaceted motor and cognitive process, in which the patient experiences tiredness and lack of energy that develops during physical or mental activity which may persist for years. Post-stroke fatigue impacts the mental/physical functions of the patient through decreased energy, and thus, is a significant barrier to recovery.
Preliminary evidence indicates sensory rehabilitation may enhance motor recovery in people with stroke. Cognitive Multisensory Rehabilitation (CMR) is a therapist-guided sensorimotor rehabilitation approach, that targets the patients' ability to solve sensory discrimination exercises, where the patient compares the sensations felt by the hand to the shapes observed with the eyes. Cognitive processes are encouraged by asking the patient to determine the limb movement or its position, how the movement was felt in the body, how the limb moved in relation to other parts of the body, and to spatial parameters in the environment. Because CMR integrates cognitive processes with sensory and motor tasks, it may be a novel method to address post-stroke fatigue, and it may increase connectivity in sensory and motor areas of the brain.
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
Giza Governorate
-
Cairo, Giza Governorate, Egitto, 12612
- Faculty of Physical Therapy Cairo University
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Age between 45 and 65 years.
- 6-18 months after ischemic stroke
- living in the community (i.e., not in a long-term care home).
- medically stable.
- normal score in the Montreal Cognitive Assessment (MoCA: 25 to 30, maximum score = 30).
- Spasticity of upper limb muscles ranged from (grade 1:2) according to the Modified Ashworth scale.
Exclusion Criteria:
- severe spasticity (Modified Ashworth Scale score of 4)
- any medical condition that hinders full participation,
- another neurological diagnosis beyond stroke including cognitive impairment, or
- upper extremity pain > 4/10 on the Numeric Pain Rating Scale (maximum 10/10).
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Prevenzione
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Doppio
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Comparatore attivo: Group 1 (GA)
20 Egyptian ischemic stroke patients receive 12 sessions of CMR and traditional physical therapy each session lasts for 40 minutes of CMR and 30 minutes of traditional physical therapy. |
Kinetic awareness: Initially, only one joint will be moved at a time. Then the therapist will reposition the joint and ask the participants to report their perception of the joint position. Initially, the participants will distinguish between just two positions. If they reliably answer correctly, increase up to five points and integrate speed and dexterity in functional movements. Participants will be asked to relax and feel the movement during this training. Discrimination exercise: The therapist places a part of the participant's limb, the fingertip, on an external object (a block) and the participant will be asked to actively move his or her limb over the object and try to sense the shape of the object. If the participants differentiate between the two objects, then increase the number of objects (up to five). Functional training: The patient reaches toward many objects functionally (cup, ball, cane) from different angles, holds them, and relocates them again. The selected physical therapy program session will be occupational therapy training for the hand, strengthening exercises for the weak upper limb stretching exercises for short upper limb muscles, balance exercise, and gait training. |
|
Comparatore fittizio: Group 2 (GB)
20 Egyptian ischemic stroke patients receive 12 sessions of traditional physical therapy each session lasts for 30 minutes. |
The selected physical therapy program session will be occupational therapy training for the hand, strengthening exercises for the weak upper limb stretching exercises for short upper limb muscles, balance exercise, and gait training. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Fugl-Meyer Assessment for upper extremity (FMT-UE).
Lasso di tempo: from baseline to four weeks after the beginning of intervention
|
Changes in upper limb function. |
from baseline to four weeks after the beginning of intervention
|
|
Serum levels of Brain-Derived Neurotrophic Factor (BDNF)
Lasso di tempo: from baseline to four weeks after the beginning of intervention
|
Changes in serum levels of neural plasticity factors |
from baseline to four weeks after the beginning of intervention
|
|
Changes in hand grip strength
Lasso di tempo: from baseline to four weeks after the beginning of intervention
|
Hand grip strength was measured by an electronic hand dynamometer device. |
from baseline to four weeks after the beginning of intervention
|
|
Fatigue Assessment Scale (FAS)
Lasso di tempo: from baseline to four weeks after the beginning of intervention
|
determine the degree of self-reported fatigue in daily living activities. Each item of the FAS is answered using a fi ve-point, Likert-type scale ranging from 1 ("never") to 5 ("always"). Items 4 and 10 are reverse-scored. Total scores can range from 10, indicating the lowest level of fatigue, to 50, denoting the highest. |
from baseline to four weeks after the beginning of intervention
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Box and Blocks Test (BBT)
Lasso di tempo: from baseline to four weeks after beginning of the intervention.
|
Changes in gross hand function intervention. |
from baseline to four weeks after beginning of the intervention.
|
Collaboratori e investigatori
Sponsor
Investigatori
- Direttore dello studio: Nahed Salem, professor, Cairo University
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- CMR stroke
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .